Hamzah Bakouni, Heidar Sharafi, Arash Bahremand, Sarah Drouin, Daniela Ziegler, Paxton Bach, Bernard Le Foll, Christian G Schütz, Vitor Tardelli, Nadine Ezard, Krista Siefried, Didier Jutras-Aswad
BACKGROUND: This meta-analysis (PROSPERO-ID: CRD42022362962), pooled effect estimates of outcomes, from placebo-controlled randomized clinical trials (RCTs) examining bupropion efficacy and safety for amphetamine-type stimulant use disorder (ATSUD) treatment. METHOD: Electronic databases were searched for records published to October 31st, 2022, including MEDLINE, CINAHL, PsycINFO, EBM Reviews, EMBASE, PubMed, Web of Science, trial registries. Inclusion criteria were RCTs comparing bupropion to placebo in ATSUD...
November 4, 2023: Drug and Alcohol Dependence